Stock NAMS FRAZIER LIFESCIENCES ACQUISITION CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Frazier Lifesciences Acquisition Corporation

Equities

NAMS

NL00150012L7

End-of-day quote Nasdaq
Other stock markets
 06:00:00 2024-06-04 pm EDT 		5-day change 1st Jan Change
19.22 EUR +1.91% Intraday chart for Frazier Lifesciences Acquisition Corporation +2.51% +72.07%
May. 21 NewAmsterdam Pharma Company N.V. to Present New Clinical and Preclinical Data Highlighting Obicetrapib's Impact on Key RiskFactors for Cardiovascular Disease at Upcoming Medical Meetings CI
May. 16 Transcript : NewAmsterdam Pharma Company N.V. - Special Call

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. NAMS Stock
  4. Revisions Frazier Lifesciences Acquisition Corporation